Effectiveness of Sensor-Augmented Insulin-Pump Therapy in Type 1 Diabetes

Bergenstal, Richard M., Tamborlane, William V., Ahmann, Andrew, Buse, John B., Dailey, George, Davis, Stephen N., Joyce, Carol, Peoples, Tim, Perkins, Bruce A., Welsh, John B., Willi, Steven M., Wood, Michael A.·2010·New England Journal of Medicine
DOI 10.1056/nejmoa1002853

Cited by (894)

Items 801–894 of 894

  1. Co nowego w terapii cukrzycy typu 1
    Anna Noczyńska, Agnieszka Zubkiewicz‐Kucharska, Julita Nocoń-Bohusz · 2012 · Family Medicine & Primary Care Review
  2. Supporting patients with type 1 diabetes
    Anne Phillips · 2017 · Practice Nursing
  3. ¿Dónde queda la glucemia capilar después del estudio IMPACT? Implicaciones de una nueva forma de medir la glucosa en la práctica clínica diaria
    Eva Aguilera, Federico Vázquez · 2017 · Endocrinología Diabetes y Nutrición
  4. Kontinuierliche Glukosemessung (CGM) bei Erwachsenen
    Bernhard Gehr · 2017 · Der Diabetologe
  5. Where does capillary blood glucose stand following the IMPACT trial? Implications of a new way of measuring glucose in routine clinical practice
    Eva Aguilera, Federico Vázquez · 2017 · Endocrinología Diabetes y Nutrición (English ed )
  6. Epidemiological characterization of diabetic patients on therapy with continuous subcutaneous insulin infusion and continuous glucose monitoring in real time
    Natalia Aristizábal, Álex Ramírez, Jaime Alejandro Hincapié-García, Estefany Laiton, Carolina Aristizábal, Diana Cuesta, Claudia Monsalve, Gloria Hincapié, Eliana Zapata, Verónica Abad et al. · 2015 · Endocrinología y Nutrición (English Edition)
  7. Continuous Subcutaneous Insulin Infusion for Adults with Type 1 Diabetes Mellitus
    Tatyana Shamliyan, Clare J. Lee · 2017 · The American Journal of Medicine
  8. Moving Islet Cell Xenotransplantation to the Clinic
    Wayne John Hawthorne · 2017 · InTech eBooks
  9. Diabète de type1: pompeàinsuline
    Éric Renard · 2017
  10. Diabetes mellitus Typ 1 – neue Entwicklungen in der intensivierten Insulintherapie
    Philipp A. Gerber, Daniel Zimmermann, Giatgen A. Spinas · 2013 · Swiss Medical Forum ‒ Schweizerisches Medizin-Forum
  11. The burden of uncontrolled A1C in type 1 diabetes: 30 years of insights from the DCCT/EDIC study
    Giampaolo Greco, David Wing-Hang Lam · 2018 · Journal of Diabetes and its Complications
  12. Effect of use of insulin pump with low glucose suspend feature on metabolic control in children with type 1 diabetes
    Vesna Miljković · 2018 · Биомедицинска истраживања
  13. Using error grid analysis to assess blood glucose estimation accuracy in adolescents with type 1 diabetes
    Natalie E. Benjamin, Astrida Seja Kaugars · 2018 · Children s Health Care
  14. Glycaemic control in pregnancies complicated by type 1 diabetes
    Stewart, Zoe Alexandra · 2017 · Apollo (University of Cambridge)
  15. Insulin pumps
    Dace Trence, Irl B. Hirsch · 2015 · Wiley eBooks
  16. Basal Insulin Adjustments and Continuous Glucose Monitoring During Exercise in Type 1 Diabetes
    Dessi P. Zaharieva · 2018 · YorkSpace (York University)
  17. Características clínicas, esquemas de tratamiento, grado de control y variables asociadas a este en una cohorte de adultos con diabetes mellitus tipo 1 en un centro terciario
    Bruno A. Grassi, Luciano Tapia, Ismael Aracena, R. Astudillo, Fernanda Kara, Margot Aliste, María Teresa Onetto, Pamela Morales Matamala · 2019 · Revista médica de Chile
  18. Assessment of glucose kinetics with real‐time continuous glucose monitoring during labor
    Jota Maki, Eriko Eto, Shoko Tamada, Takashi Mitsui, Kei Hayata, Keiichiro Nakamura, Yuji Hiramatsu, Hisashi Masuyama · 2019 · Journal of obstetrics and gynaecology research
  19. A diabeteses fiatal átvétele a gyermekgyógyásztól – Átadás-átvétel a belgyógyász-diabetológus szemszögéből
    Éva Katona · 2018 · Diabetologia Hungarica
  20. New technologies for the treatment of diabetes mellitus
    Andreas Thomas · 2015
  21. Hypoglykämien bei Diabetes mellitus: häufig und gefährlich
    Andreas Holstein, David J.F. Holstein · 2019 · Diabetes aktuell
  22. Pharmacodynamic Evaluation: Diabetic Methodologies
    JUERGEN SANDOW · 2019 · Springer eBooks
  23. Using survival modelling as a composite measure of outcome to demonstrate insulin pump therapy effectiveness in type 1 diabetes
    Liana Yamanouchi, Wen Bun Leong, Joanne Lloyd, Angela Smith, P.H. O'Connor Davies, Ansu Basu · 2020 · Practical Diabetes
  24. WITHDRAWN: A Comparison of Internet Monitoring with Continuous Glucose Monitoring in Insulin-Requiring Type 2 Diabetes Mellitus
    Hugh D. Tildesley, Anthony M. Wright, Jeremy H.M. Chan, Adel B. Mazanderani, Stuart A. Ross, Hamish G. Tildesley, Augustine M. Lee, Tricia S. Tang, Adam S. White · 2016 · Canadian Journal of Diabetes · Retracted
  25. Impacto de la utilización de sistemas de medición de glucosa intersticial en el control glucémico en pacientes pediátricos con diabetes mellitus tipo 1
    Sara María Barbed Ferrández, Teresa Montaner Gutiérrez, Gemma Larramona, Marta Ferrer Lozano, Gracia María Lou Francés · 2020 · Revista Mexicana de Pediatría
  26. Clinical impact of CGM use
    Chukwuma N. Uduku, Monika Reddy, Nick S. Oliver · 2020 · Elsevier eBooks
  27. Part II : Subcutaneous insulin infusion devices
    John Michael Moorman · 2020 · JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY
  28. Diabetes type 1 and type 2—Insulin delivery systems
    Eva Wong, Rajesh Vadlapatla, Candis M. Morello · 2020 · Elsevier eBooks
  29. ISPAD Clinical Practice Consensus Guidelines 2018. Chapter 8. Glycemic control targets and glucose monitoring for children, adolescents, and young adults with diabetes
    Prepared by N. B. Zelinska · 2020 · Ukrainian Journal of Pediatric Endocrinology
  30. Induced Hyperglycemia in Mice is Controlled Following the Microfluidic System- Assisted Transplantation of Stem Cells-derived Insulin-producing Cells Transduced with miRNA
    A Soltani, Masoud Soleimani, Mohammad Adel Ghiass, Seyed Ehsan Enderami, Shahram Rabbani, Arefeh Jafarian, Abdolamir Allameh · 2020
  31. Technological devices in treatment of diabetes mellitus
    Cem Onur Kıraç, Süleyman Hilmi İpekçi · 2021 · Journal of Bionic Memory
  32. Does HbA1c Remain the Most Important Therapeutic Target in Outpatient Management of Diabetes?
    Kristen M. Gonzales, Steve Smith · 2021 · Wiley eBooks
  33. De tbs met aanwijzing
    Ed. Leuw · 1993 · Data Archiving and Networked Services (DANS)
  34. Hypoglycemia in Diabetes Mellitus
    Mazen Alsahli, John E. Gerich · 2017 · Springer eBooks
  35. Thérapeutique des désordres glycémiques
    2019 · Elsevier eBooks
  36. Hypoglycemia
    Elizabeth Mary Lamos, Lisa M. Younk, Stephen N. Davis · 2018 · Wiley eBooks
  37. Hypoglycemia in Diabetes Mellitus
    Mazen Alsahli, John E. Gerich · 2015 · Springer eBooks
  38. Hypoglycaemia in Diabetes
    Elaine Chow, Simon R. Heller · 2022 · Springer eBooks
  39. The effectiveness of a comprehensive diabetes program for glycemic control and adherence, and the selection of candidates for sensor-augmented insulin pump therapy
    José Fernando Botero, Luz Marcela Vásquez, V. M. Blanco, Diana Cuesta, Alex Ramírez Rincón, Jorge Bedoya, Andrés Palacio · 2021 · Endocrinología Diabetes y Nutrición (English ed )
  40. Treatment
    Richard F. Dods · 2013 · Wiley eBooks
  41. Diabetes Technology and Treatment in the Paediatric Age Group
    Shlomit Shalitin, H. Peter Chase · 2012 · Wiley eBooks
  42. Insulines
    Sébastien Faure · 2012 · Actualités Pharmaceutiques
  43. Metabolic control after years of completing a clinical trial on sensor-augmented pump therapy
    Carmen Quirós, Marga Giménez, Aida Orois, Ignacio Conget · 2015 · Endocrinología y Nutrición (English Edition)
  44. Type 1 diabetes: technology and transplants
    David Levy MD FRCP · 2017 · Wiley eBooks
  45. Faster-acting insulin aspart reduces glycaemic variability in sensor-augmented pump treated type 1 diabetes patients
    Jesús Moreno-Fernández, José Alberto García-Seco, Rita Virlaboa-Cebrian, Angela María Seco, José Ramón Muñoz‐Rodríguez, Francisco Javier Gómez Romero · 2022 · Endocrinología Diabetes y Nutrición
  46. Diagnostik, Therapie und Verlaufskontrolle des Diabetes mellitus im Kindes- und Jugendalter
    Andreas Neu, Jutta Bürger-Büsing, Thomas Danne, Axel Dost, Martin Holder, Reinhard Walter Holl, Paul‐Martin Holterhus, Thomas Michael Kapellen, Beate Karges, Olga Kordonouri et al. · 2022 · Die Diabetologie
  47. Diabetestechnologie bei Kindern und Jugendlichen mit Diabetes mellitus Typ 1
    Birgit M. Rami-Merhar · 2022 · Die Diabetologie
  48. Uso de microinfusor de insulina con sistema integrado en pacientes pediátricos con diabetes tipo 1: resultados metabólicos iniciales
    Carolina Wong Lam, Josefa Hurtado Navarro, Rocío Fuentes Díaz, Elizabeth Toro Toro, Bárbara Reyes Espejo · 2022 · Andes pediatrica
  49. Il monitoraggio in continuo della glicemia: stato dell’arte
    Concetta Irace, Sergio Di Molfetta · 2022 · il Diabete
  50. The psychological and health benefits of using a continuous glucose monitor for a person with type 1 diabetes: A South African higher education context
    Rossano Wells, Anria Knowles · 2023 · F1000Research
  51. RESISTENCIAS O MAL USO DE LOS ANTIBIÓTICOS
    TAMAR BLANCA SERRANO · 2022
  52. Partially Observable Reinforcement Learning for Blood Glucose Control Under Missing Data
    Haiyan Yu, Jiao Xiang, Nan Kong, Li Luo, Ching‐Chi Yang · 2023 · SSRN Electronic Journal
  53. Hypoglycaemia in Diabetes
    Ahmed Iqbal, Elaine Chow, Timothy William Jones, Simon R. Heller · 2024 · Wiley eBooks
  54. New Technologies for Insulin Administration
    Hannah Elizabeth Forde, Pratik Choudhary · 2024 · Wiley eBooks
  55. Impact of insulin pump therapy on glycemic control , and body mass index on Type 1 diabetes mellitus, Tripoli Libya.
    Bahlul Ben Masaud, Darin Meeteig, Khawla Ameed, Najwi Mudallal, Salsabil Keshlaf, Enas Azzabi, Ibtihal Shagrouni, Walid Shekiry, Sanira Nowara, Ayman Derbash et al. · 2021 · Libyan Journal of Medical Research
  56. Elevated urinary albumin predicts increased time in range after initiation of SGLT2 inhibitors in individuals with type 1 diabetes on sensor-augmented pump therapy
    Yuka Suganuma, Mizuki Ishiguro, Takayuki Ohno, Rimei Nishimura · 2024 · Diabetology International
  57. Pump Therapy Management (Keeping Patients On The Pump)
    2024 · American Diabetes Association eBooks
  58. Integrating Nutrition Therapy, Blood Glucose Monitoring, and Continuous Glucose Monitoring
    L. Lyons, Margaret A. Powers, Mary M. Austin · 2017 · American Diabetes Association eBooks
  59. Clusters of Nocturnal Glucose Dynamics in Patients with Type 1 Diabetes Managed by Continuous Subcutaneous Insulin Infusion
    Danil E. Kladov, Julia F. Semenova, Vladimir Berikov, Vadim Valer'evich Klimontov · 2024 · International Multi-Conference on Engineering, Computer and Information Sciences (SIBIRCON)
  60. Impact of a COVID-19 emergency declaration on blood glucose levels in individuals with type 1 diabetes treated with a sensor-augmented pump
    Tomofumi Takayoshi, Yushi Hirota, Akane Yamamoto, Kai Yoshimura, Seiji Nishikage, Mariko Ueda, Wataru Ogawa · 2025 · Diabetology International
  61. Case 88: The Use of Medical Technologies for the Reduction of Hypoglycemia in Type 1 Diabetes: Technology for Hypoglycemia Reduction
    Viral N. Shah, Aaron W. Michels, Satish K. Garg · 2015 · American Diabetes Association eBooks
  62. Insulin Pump Therapy in Libya: A Comparative Study on Glycemic Control and Patient Outcomes in Type 1 Diabetes
    Khalid Milad, Shahir Ghiath, Mohmmed Sehaib · 2025 · Libyan Medical Journal
  63. Tecnología al rescate: detección y prevención de hipoglucemia inducida por aztreonam mediante monitoreo continuo de glucosa
    Thomas Betancourt, Daniela González-Guerrero, Darlenys Meneses, Zully Andreína Réquiz, L.R. Gaslonde Betancourt, Juan Guillermo Lopez Celis, Fernando Carrera Viñoles · 2025 · Diabetes actual
  64. Safe-Predictive Control of Artificial Pancreas for Hyperglycemia and Hypoglycemia Risk Mitigation
    Aliasghar Arab, Yashar Mousavi · 2025
  65. A clinical case of the use of a closed loop system in the treatment of type 1 diabetes mellitus
    A. S. Teplova, A. Parkhomenko, K. Petrosyan · 2025 · FOCUS.Endocrinology
  66. No evidence from euglycaemic–hyperinsulinaemic clamp studies for greater insulin sensitivity in adults with type 1 diabetes using insulin pump versus multiple daily insulin injections—Post hoc meta‐analysis
    Andrzej S. Januszewski, JENNIFER R. SNAITH, Agata Grzelka‐Woźniak, Johan R. Simonsen, Nirupa Sachithanandan, Glenn M. Ward, David Norman O'Neal, Daniel Gordin, Lena M. Thorn, Per‐Henrik Groop et al. · 2025 · Diabetes Obesity and Metabolism
  67. Achieving meaningful reduction of HgbA1c in pediatric type 1 diabetes requires an individualized approach
    Andrew Kanouse, Joanna Stein Fishbein, Parissa Salemi · 2025 · Primary care diabetes
  68. Risk-Aware Control for Insulin Delivery via Nonlinear MPC with Safety Barrier Functions and Probabilistic Learning of Uncertainties
    Aliasghar Arab, Seyedreza Mohamadi, Farid Alisafaei, Yashar Mousavi, Katsuo Kurabayashi · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  69. Comparative Study of Glycemic Control and Treatment Satisfaction in Patients With Type 1 Diabetes on Sensor-Augmented Insulin Pump, Insulin Pump, and Multiple Daily Insulin Injections: A Cross-Sectional Study
    Ali A Alshahrani, Fajr Mutairi · 2025 · Cureus
  70. Additional file 3 of Impact on Glycemia Risk Index and other metrics in type 1 adult patients switching to Advanced Hybrid Closed-Loop systems: a one-year real-life experience
    Eugenia Resmini, Emanuela Zarra, Dotti, Silvia, Rotondi, Giulia, Angelo Vincenzo Cornaghi, Sara Madaschi, Elena Cimino, Massari, Giulia, Letizia Chiara Pezzaioli, Caterina Buoso et al. · 2024 · Figshare
  71. Additional file 1 of Effectiveness and safety of a model predictive control (MPC) algorithm for an artificial pancreas system in outpatients with type 1 diabetes (T1D): systematic review and meta-analysis
    Kang, Su Lim, Hwang, Yoo Na, Kwon, Ji Yean, Sung Min Kim · 2024 · Figshare
  72. Additional file 1 of Effects of the timing of the initiation of dietary intake on pediatric type 1 diabetes for diabetic ketoacidosis
    Yuan, Xuewen, Jieguo Wang, Chen, Xiaofeng, Yan, Wu, Niu, Qing, Ning Tang, Zhang, Ming Zhi, Gu, Wei, Wang, Xu · 2022 · Figshare
  73. Additional file 1 of Impact on Glycemia Risk Index and other metrics in type 1 adult patients switching to Advanced Hybrid Closed-Loop systems: a one-year real-life experience
    Eugenia Resmini, Emanuela Zarra, Dotti, Silvia, Rotondi, Giulia, Angelo Vincenzo Cornaghi, Sara Madaschi, Elena Cimino, Massari, Giulia, Letizia Chiara Pezzaioli, Caterina Buoso et al. · 2024 · Figshare
  74. Additional file 2 of Impact on Glycemia Risk Index and other metrics in type 1 adult patients switching to Advanced Hybrid Closed-Loop systems: a one-year real-life experience
    Eugenia Resmini, Emanuela Zarra, Dotti, Silvia, Rotondi, Giulia, Angelo Vincenzo Cornaghi, Sara Madaschi, Elena Cimino, Massari, Giulia, Letizia Chiara Pezzaioli, Caterina Buoso et al. · 2024 · Figshare
  75. Real-time physical activity detection module during sensor augmented insulin pump therapy
    Eleonora Manzoni, Emilia Fushimi, Eleonora M. Aiello, Zoey Li, Robin L. Gal, Corby K. Martin, Susana R. Patton, Simone Del Favero, Francis J. Doyle · 2025 · Journal of Process Control
  76. T1D-MLLM: Multimodal Large Language Model and Cross-Scenario Dataset for Multi-Scenario Management of Type 1 Diabetes
    Liangliang Liu, Yi Guan, Yanming Li, Rujia Shen, Guowei Zheng, Chaoran Kong, Jingchi Jiang, Yi Lin · 2025 · IEEE International Conference on Bioinformatics and Biomedicine (BIBM)
  77. Further Advances
    Val Wilson · 2026 · Springer eBooks
  78. Wearable from the Perspective of Healthcare Professionals
    Rana Özyurt Kaptanoğlu · 2025 · Balkan Journal of Electrical and Computer Engineering
  79. Causal mediation pathways in continuous postprandial glucose monitoring for type 1 diabetes patients
    Spencer Hilligoss, Annie Qu · 2026 · npj Metabolic Health and Disease
  80. Health care Professional–Supervised Use of Intermittently Scanned Continuous Glucose Monitoring During a Pediatric Type 1 Diabetes Summer Camp: A Prospective Observational Study
    Tatsuya Kondo, Takafumi Senokuchi, Mayumi Yano, Haruo Takeda, Kenro Nishida, Yutaka Kai, Naoto Kubota · 2026 · Diabetes Technology and Obesity Medicine
  81. Communications intercellulaires dynamiques au sein des îlots pancréatiques analysées par multi-electrode arrays : rôles physiologiques et applications biotechnologiques en diabétologie
    Manon Jaffredo · 2021 · theses.fr (ABES)
  82. In silico development of a bioelectronic islet-based artificial pancreas
    Loïc Olçomendy · 2021 · theses.fr (ABES)
  83. Association Between Real-Time Continuous Glucose Monitoring Sensor Active Time and Glycemic Metrics in Patients With Diabetes: A Real-World Setting Analysis
    Lamya Mohammed Yahya Alzubaidi, Faisal Alenezi, Abdullah M Alsoheimi, Abdullah Mohammed Arabe, Amera S Alrshood, Muna Hassanein, ABDULMOHSEN BAKHSH · 2026 · Journal of Diabetes Science and Technology
  84. Partially observable reinforcement learning for blood glucose control under missing data
    Jiao Xiang, Nan Kong, Ching‐Chi Yang, Li Luo, Haiyan Yu · 2026 · Computers & Industrial Engineering
  85. Weekly Glucagon-Like Peptide-1 Receptor Agonists in Type 1 Diabetes
    Amy Buros‐Stein, MEGHAN E. PAULEY, Janet K. Snell‐Bergeon · 2026 · Endocrinology and Metabolism Clinics of North America
  86. Diabetestechnologie (Update 2026)
    Ingrid Schütz-Fuhrmann, Birgit M. Rami-Merhar, Sabine E. Hofer, Elke Elisabeth Fröhlich-Reiterer, Martin Tauschmann, Julia Katharina Mader, Michael Resl, Alexandra Kautzky‐Willer, Yvonne Winhofer-Stöckl, Thomas C. Wascher et al. · 2026 · Wiener klinische Wochenschrift
  87. Long-term efficacy and safety of sensor-augmented pump for type 1 diabetes
    Satoshi Takagi, Junnosuke Miura, Mikako Takita, Shota Mochizuki, Kanako Shimura, Sari Hoshina, Hiroko Takaike, Tetsuya Babazono · 2026 · Diabetology International
  88. Role of vasular endothelial growth factor (VEGF) in diabetic complication
    Neeraj Kumar, Shubham Kumar, Rakesh Kumar Sharma, Bimlesh Kumar, Pavas Sharma, Akash Jain, Abhijit Debnath, Promila Sharma, Shivani Verma · 2026 · AIP conference proceedings
  89. Insulin Delivery and Technology
    Reshma Parab, Mandar Shirke · 2026 · Springer eBooks
  90. Current options in insulin pump therapy for diabetes
    Lucie Radovnická · 2026 · Klinická farmakologie a farmacie
  91. "Qandli diabet bilan ogʻrigan bemorlarda glyukoza monitoringi va uning turmush sifatiga taʼsiri"
    Xusen Qurbonov, Dilorom Mardonova, Djamshir Uzakov · 2025
  92. Ultraflexible Multimodal Sensors with Stable Physical Sensing and Disposable Electrochemical Calibration for Long-Term Glucose Prediction
    Xuyang Feng, Jiahe Zhou, Xianyu Wang, Binghao Wang · 2026 · ACS Sensors
  93. BindingDB Entry 50007932: The Immunoproteasome: An Emerging Target in Cancer and Autoimmune and Neurological Disorders.
    BindingDB · 2021 · UC San Diego
  94. わが国における糖尿病診療と教育活動の実態(第5報)-2012年度全国アンケート調査より-
    鈴木 和枝, 弘美 藤田, Naohiko Hashiba, 光隆 本吉, 池田 義雄 · 2015 · 糖尿病